Registry Data Show Vedolizumab, Ustekinumab Safe in Pregnancy

PDF) Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study

ustekinumab gutsandgrowth

Stelara Full Prescribing Information, Dosage & Side Effects

Next generation of biologics for the treatment of Crohn's disease: an evidence-based review on ustekinumab. - Abstract - Europe PMC

Vedolizumab: Uses, Interactions, Mechanism of Action

About IBD Podcast Episode 92 - IBD and Pregnancy With Jill Gaidos, MD

Ulcerative Colitis—Diagnostic and Therapeutic Algorithms (17.08.2020)

Ustekinumab in Dermatology: Approved Indications and Off-label Uses

View of Inflammatory bowel disease and pregnancy: fertility, complications and treatment

CSGH

vedolizumab - Gastroenterology & Endoscopy News

Full article: Prospective observational study on Stelara (ustekinumab) assessing effectiveness in Crohn's disease (PROSE): a 16-week follow-up

These highlights do not include all the information needed to use XELJANZ/XELJANZ XR/XELJANZ Oral Solution safely and effectively. See full prescribing information for XELJANZ/XELJANZ XR/XELJANZ Oral Solution. XELJANZ® (tofacitinib) tablets, for oral

Use of vedolizumab throughout pregnancy. Trimester 1: exclusion of 12